Metraipolis › archive › dc_c0ee558e6ab0

Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window — Europe PMC PMID:41514136

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514136
DOI
10.1007/s12035-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-06T22:20:48.838Z
SHA-256 of the archived text
d882a94cfe187bff0229db8b8e0e79204397788085abe3131ca931bbff348167
Stable URL of this page
https://metraipolis.com/documento/dc_c0ee558e6ab0

How to cite

Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window — Europe PMC PMID:41514136 — Europe PMC (en), https://europepmc.org/article/MED/41514136 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c0ee558e6ab0 (Metraipolis archive dc_c0ee558e6ab0, sha256 d882a94cfe187bff0229db8b8e0e79204397788085abe3131ca931bbff348167)
BibTeX
@misc{dcc0ee558e6ab0,
  title = {Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window — Europe PMC PMID:41514136},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514136},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c0ee558e6ab0; sha256 d882a94cfe187bff0229db8b8e0e79204397788085abe3131ca931bbff348167},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514136. Agents can read the archived copy with the MCP tool read_document.